Masahiko Shibuya

Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

Kaoru Kubota, Koshiro Watanabe, Hideo Kunitoh et al. · Journal of Clinical Oncology · 2004 · 232 citations · Full text

Medicine, Oncology, Pharmacology +13

Accuracy of OCT, Grayscale IVUS, and Their Combination for the Diagnosis of Coronary TCFA

Kenichi Fujii, Hiroyuki Hao, Masahiko Shibuya et al. · JACC. Cardiovascular imaging · 2015 · 146 citations

Medicine, Cardiology, Radiology +14

Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing

Carlos A. Gongora, Masahiko Shibuya, Jeffrey D. Wessler et al. · JACC: Cardiovascular Interventions · 2015 · 117 citations

Medicine, Pharmacokinetics, Pharmacology +14

Somatic mutation of thehBUB1 mitotic checkpoint gene in primary lung cancer

Akihiko Gemma, Masahiro Seike, Yoko Seike et al. · Genes Chromosomes and Cancer · 2000 · 82 citations

Medicine, Genetics, Oncology +17

Identification of an Active Site on the Laminin α5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy

Suguru Hibino, Masahiko Shibuya, Jean A. Engbring et al. · Cancer Research · 2004 · 73 citations

Life Sciences, Molecular Biology, Oncology +16